In a nutshell This study investigated the long-term effectiveness bevacizumab (Avastin) with chemotherapy for HER2-negative locally recurrent/metastatic breast cancer. This study concluded that while bevacizumab combined with chemotherapy significantly improved time to disease progression compared with chemotherapy alone in the first two phases...
Read MoreCurrent stage?-Stage III Posts on Medivizor
Is there a benefit of radiation to lymph node metastases during hormone therapy?
In a nutshell This study examined the benefit of radiation to limited sites of cancer spread (metastases) in men no longer responding to hormone therapy. Researchers reported effective local cancer control after radiation of lymph node metastases in patients no longer responding to hormone therapy. Some background Hormone therapy is the...
Read MoreExamining surgery as a primary treatment for high-risk prostate cancer
In a nutshell This study examined evidence for the role of prostate surgery in treating high-risk prostate cancer. Authors concluded that surgery is an effective primary treatment option for men with high-risk disease. Some background Localized prostate cancer is cancer that is confined to the prostate gland. Men with high-risk localized prostate...
Read MoreShould immunotherapy be administered before or after hormone therapy?
In a nutshell This study examined whether immunotherapy with sipuleucel-T (Provenge) shows a greater immune response if administered before or after androgen deprivation therapy (ADT). Authors present preliminary evidence of improved immune cell response when sipuleucel-T was administered first in patients with recurrent prostate cancer at high risk of...
Read MoreWhat Is Considered Early Stage Lung Cancer and How Is It Treated?
Transcript Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. Janet...
Read MoreHigh-risk prostate cancer: Is there a survival benefit when chemotherapy is administered before surgery?
In a nutshell This study examined the benefit of administering chemotherapy before prostate surgery in men with intermediate- to high-risk prostate cancer. Researchers reported preliminary evidence of a cancer-specific survival benefit when chemotherapy was administered before surgery. Some background Prostate surgery is a first-line treatment for...
Read MorePre-surgery chemotherapy and radiation therapy improves the outcomes of locally advanced rectal cancer
In a nutshell This study investigated the benefits of pre-surgery chemotherapy and radiation therapy (CRT) in patients with rectal cancer and pelvic lymph node metastasis (spread of cancer). Researchers suggested that CRT may have a beneficial impact in the disease outcomes of these patients. Some background CRT followed by surgery is the...
Read MoreAdvanced Prostate Cancer: Are Immunotherapy Approaches Available?
Are there any immunotherapy approaches currently available to advanced prostate cancer patients? Patient Power Founder and Host, Andrew Schorr, leads a discussion with prostate cancer experts Dr. William Catalona of Lurie Cancer Center and Dr. Russell Szmulewitz on immunotherapy research. Dr. Szmulewitz gives a short account of immunology...
Read MorePrognostic factors for stage 3b melanoma outcomes
In a nutshell This study investigated the predictive factors for the outcomes of stage 3b melanoma. Researchers suggested that patients older than 50 years old, with tumors thicker than 2 mm and positive pelvic lymph nodes are more at risk of death by stage 3b melanoma. Some background The incidence of melanoma has been rising worldwide....
Read More10 years on: Comparing treatment options for localized prostate cancer
In a nutshell This study compared the effectiveness of different treatment options available for localized prostate cancer. Authors reported low rates of prostate cancer-specific mortality across all treatment groups. However, surgery and radiation therapy were associated with a lower rate of disease progression and metastases compared to active...
Read MoreGranulocyte-macrophage colony-stimulating factor (GM-CSF) with melanoma vaccine combined treatment does not improve survival in advanced melanoma
In a nutshell This study investigated the effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) and peptide vaccination (PV) on survival of patients with advanced melanoma. Researchers suggested that neither GM-CSF nor PV were associated with improved survival. Some background GM-CSF stimulates the immune system to produce more...
Read MoreDifferent chemotherapy regimens in combination therapy with radiation to treat locally advanced NSCLC
In a nutshell The authors compared the effectiveness of different chemotherapy agents in combination with radiation. They stated that a combination of etoposide (Etopophos) and cisplatin (Platinol) was more effective then docetaxel (Taxotere) and cisplatin when combined with radiation therapy. Some background...
Read More